Boston Scientific (NYSE:BSX) today announced positive real-world outcomes with its Watchman FLX left atrial appendage closure (LAAC) device. Marlborough, Massachusetts–based Boston Scientific posted data from the Surpass real-world analysis at the Cardiovascular Research Technologies (CRT) 2022 meeting. Surpass included data from more than 16,000 patients with non-valvular atrial fibrillation (AFib) within the National Cardiovascular Data […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Cardiovascular Systems, Innova Vascular partner to develop thrombectomy devices
Cardiovascular Systems (NSDQ:CSII) this week announced that it has partnered with Innova Vascular to develop a full line of thrombectomy devices. Under the terms of the agreement, Cardiovascular Systems will provide financing to Innova to develop thrombectomy devices to remove blood clots from arteries and veins. Cardiovascular Systems will have exclusive rights to acquire the devices […]
LeMaitre Vascular beats The Street in Q4, grows sales 5%
LeMaitre Vascular (NSDQ:LMAT) this week posted fourth-quarter results that beat the overall consensus forecast on Wall Street. The Burlington, Massachusetts-based company reported profits of $6.2 million, or 28¢ per share, on sales of $39.5 million for the three months ended Dec. 31, 2021, for a bottom-line loss of -12.2% on sales growth of 5.21% compared with […]
Silk Road Medical grows sales 33% in Q4
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that beat the revenue consensus on Wall Street and missed on earnings estimates. The Sunnyvale, California-based stroke treatment tech company reported losses of -$14.7 million, or -42¢ per share, on sales of $28.3 million for the three months ended Dec. 31, 2021, for a bottom-line gain of 12.3% […]
iRhythm’s fourth-quarter beats the Street as a new leader joins the ranks
iRhythm Technologies (NSDQ:IRTC) posted fourth-quarter results today that beat the consensus forecast on Wall Street while naming the high-level hire the CEO wanted to make when he last spoke with Medical Design & Outsourcing. The San Francisco-based developer of remote external electrocardiogram monitors reported a net loss of $32.5 million, or $1.10 per share, on […]
LivaNova stock up on Street-beating Q4
LivaNova (Nasdaq: LIVN) today reported fourth-quarter results that beat the consensus forecast on Wall Street, with sales expected to grow in 2022. The London-based cardiac surgery and neuromodulation device company lost $5.1 million, or 10¢ per share, off $270.1 million in sales for the quarter ended Dec. 31, 2021 — versus a loss of $281.1, […]
Penumbra posts mixed-bag Q4 results, grows sales 22%
Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Alameda, California-based company reported losses of -$24.6 million, or -66¢ per share, on sales of $204 million for the three months ended Dec. 31, 2021, for a sales growth of 22.24% compared with Q4 2020. Get […]
Front Line Medical expands availability of COBRA-OS arterial occlusion system
Front Line Medical recently announced that it expanded the availability of its COBRA-OS aortic occlusion device to meet growing demands. The Ontario, Canada-based company is increasing production of the COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) occluder following patient success rates and expanded interest from hospitals to treat trauma. Get the full story on […]
FDA clears Dyad Medical automated cardiac image analysis platform
Dyad Medical this week announced that it received FDA 510(k) clearance for its Libby IAAA cardiac image analysis platform. Boston-based Dyad Medical designed the Libby IAAA for image analysis used for viewing and quantifying intravascular optical coherence tomography (IVOCT) images. It allows healthcare professionals to automate intravascular investigation and see inside of blood vessels to […]
FDA approves expanded indication for Abbott’s CardioMEMS
The FDA has expanded the number of people who can use Abbott’s tiny implantable CardioMEMS heart failure sensor. The approval of the expanded indication, announced yesterday, means that an additional 1.2 million people in the U.S. with heart failure could take advantage of the Abbott system. The CardioMEMS HF system remotely monitors pulmonary artery (PA) […]
Medtronic wins FDA expanded approval to use cardiac cryoablation catheters in kids
Medtronic today announced that it received FDA expanded approval for its Freezor and Freezor Xtra cardiac cryoablation catheters for pediatric atrioventricular nodal reentrant tachycardia (AVRNT). AVNRT is the most common form of supraventricular tachycardia and involves a life-threatening abnormal heart rhythm. More than a third of AVRNY cases are in pediatrics or children under the age […]